Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions

Elisa Roca (Rezzato, BS, Italy), Elisa Roca, Romaric Lacroix, Coralie Judicone, Sophie Laroumagne, Stephane Robert, Sylvie Cointe, Alexandre Muller, Elise Kaspi, Patrice Roll, Alain Brisson, Claudio Tantucci, Philippe Astoul, Françoise Dignat-George

Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Session: Emerging technologies for malignant pleural diseases management
Session type: Oral Presentation
Number: 5005
Disease area: Thoracic oncology

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elisa Roca (Rezzato, BS, Italy), Elisa Roca, Romaric Lacroix, Coralie Judicone, Sophie Laroumagne, Stephane Robert, Sylvie Cointe, Alexandre Muller, Elise Kaspi, Patrice Roll, Alain Brisson, Claudio Tantucci, Philippe Astoul, Françoise Dignat-George. Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions. Eur Respir J 2015; 46: Suppl. 59, 5005

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of Dr-70 immunoassay in suspected malignant pleural effusion
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Comparison analysis of malignant and tuberculous pleural fluid using proteomic method
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Pleural ultrasonic elastography in the diagnosis of malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013



Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


CT scanner for the pleural staging of pleural cancer: How accurate is this?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

LATE-BREAKING ABSTRACT: A proteomic study of benign and malignant pleural effusions
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015

Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Role of thoracoscopic pleural lavage and brush in undiagnosed exudative pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Risk of occult pleural infection in patients with malignant effusions
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013

Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Diagnostic accuracy of pleural fluid cytology compared to pleural biopsy histology obtained via thoracoscopy
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

High fluorescence cells in pleural fluid. Association with pleural malignancy
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013